---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000404"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2022-10-31T23:59:59+00:00"
generated_at: "2026-06-22T21:58:01.030970+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Chemed Q3 revenue down 2.3% to $526M; raises 2022 adjusted EPS guidance to $19.60-$19.70

## Summary
- GAAP diluted EPS of $3.78; adjusted diluted EPS of $4.74, down 6.3% YoY.
- VITAS net revenue fell 6.6% to $297M; ADC down 4.4% to 17,242; admissions down 16.6%.
- Roto-Rooter revenue rose 3.9% to $230M; adjusted EBITDA margin improved 50bps to 30.2%.
- Company repurchased 50,000 shares for $23.9M at avg cost $477.68; $101M authorization remaining.
- 2022 adjusted EPS guidance raised to $19.60-$19.70 from $19.30-$19.50; VITAS revenue forecast down 4.5%-5%.

## SEC filing metadata
- accession: 0001562762-22-000404
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2022-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/0001562762-22-000404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/che-20221031x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000404
- JSON: https://secwatch.observer/filing/0001562762-22-000404.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000404.txt

## Key facts
- Earnings Releases
  CHEMED CORP reported third quarter ended September 30, 2022 results: revenue $526 million, EPS $3.78. Guidance raised.
  - Period: third quarter ended September 30, 2022
  - Revenue: $526 million
  - EPS: $3.78
  - Guidance: raised
  - Result: reported results
  source text: Consolidated operating results: · Revenue declined 2.3% to $526 million · GAAP Diluted Earnings-per-Share (EPS) of $3.78 · Adjusted Diluted EPS of $4.74, a decline of 6.3%
  evidence_url: https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/0001562762-22-000404-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.